Morgan Stanley’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Buy |
4,015
+482
| +14% | +$1.73K | ﹤0.01% | 6757 |
|
|
2025
Q1 | $7.6K | Hold |
3,533
| – | – | ﹤0.01% | 6884 |
|
|
2024
Q4 | $10.8K | Buy |
3,533
+3,267
| +1,228% | +$9.97K | ﹤0.01% | 6777 |
|
|
2024
Q3 | $614 | Hold |
266
| – | – | ﹤0.01% | 7278 |
|
|
2024
Q2 | $753 | Hold |
266
| – | – | ﹤0.01% | 7188 |
|
|
2024
Q1 | $1.18K | Sell |
266
-273
| -51% | -$1.21K | ﹤0.01% | 7151 |
|
|
2023
Q4 | $4.12K | Buy |
539
+270
| +100% | +$2.06K | ﹤0.01% | 7035 |
|
|
2023
Q3 | $1.95K | Hold |
269
| – | – | ﹤0.01% | 7137 |
|
|
2023
Q2 | $2.52K | Hold |
269
| – | – | ﹤0.01% | 7142 |
|
|
2023
Q1 | $4.44K | Buy |
269
+9
| +3% | +$149 | ﹤0.01% | 7080 |
|
|
2022
Q4 | $6.92K | Buy |
260
+141
| +118% | +$3.75K | ﹤0.01% | 7060 |
|
|
2022
Q3 | $5K | Sell |
119
-4,349
| -97% | -$183K | ﹤0.01% | 7251 |
|
|
2022
Q2 | $400K | Sell |
4,468
-4,429
| -50% | -$397K | ﹤0.01% | 5530 |
|
|
2022
Q1 | $768K | Sell |
8,897
-5,863
| -40% | -$506K | ﹤0.01% | 5151 |
|
|
2021
Q4 | $1.35M | Buy |
14,760
+6,350
| +76% | +$581K | ﹤0.01% | 4866 |
|
|
2021
Q3 | $1.7M | Buy |
8,410
+7,249
| +624% | +$1.47M | ﹤0.01% | 4698 |
|
|
2021
Q2 | $540K | Buy |
1,161
+1,074
| +1,234% | +$500K | ﹤0.01% | 5476 |
|
|
2021
Q1 | $18K | Buy |
+87
| New | +$18K | ﹤0.01% | 6755 |
|